Valeant Pharmaceuticals International Inc (NYSE:VRX)

During the Trading Day
117.39 -8.44 / -6.71%
Data as of 4:04pm ET
Day’s Change
During After-Hours   Switch to standard view »
115.72 -1.67 / -1.42%
 
Volume: 1.3K
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$42.0B

Company Description

Valeant Pharmaceuticals International, Inc. is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology, and branded generics. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.

Contact Information

Valeant Pharmaceuticals International, Inc.
2150, St. Elzéar boulevard Ouest
Laval Quebec H7L 4A8
P:(514) 744-6792
Investor Relations:
(949) 461-6002

Employees

Shareholders

Individual stakeholders7.28%
Other institutional51.68%
Mutual fund holders34.38%

Top Executives

J. Michael PearsonChairman & Chief Executive Officer
Howard Bradley SchillerChief Financial Officer, Director & Executive VP
Tage RamakrishnaChief Medical Officer
Jerzy JaneczkoHead-Information Technology
Susan T. HallSenior Vice President, Head-Research & Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.